|
1
|
Newman DJ and Cragg GM: Natural Products
as Sources of New Drugs over the Nearly Four Decades from 01/1981
to 09/2019. J Nat Prod. 83:770–803. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen G, Zhu M and Guo M: Research advances
in traditional and modern use of Nelumbo nucifera: Phytochemicals,
health promoting activities and beyond. Crit Rev Food Sci Nutr. 59
(sup1):S189–S209. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao T, Zhu Y, Zhao R, Xiong S, Sun J,
Zhang J, Fan D, Deng J and Yang H: Structure-activity relationship,
bioactivities, molecular mechanisms, and clinical application of
nuciferine on inflammation-related diseases. Pharmacol Res.
193:1068202023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Justino AB, Florentino RM, Franca A, Filho
ACML, Franco RR, Saraiva AL, Fonseca MC, Leite MF and Salmen
Espindola F: Alkaloid and acetogenin-rich fraction from Annona
crassiflora fruit peel inhibits proliferation and migration of
human liver cancer HepG2 cells. PLoS One. 16:e02503942021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yeh YT, Huang JC, Kuo PL and Chen CY:
Bioactive constituents from Michelia champaca. Nat Prod Commun.
6:1251–1252. 2011.PubMed/NCBI
|
|
6
|
de Lima BR, da Silva FMA, Soares ER, de
Almeida RA, da Silva-Filho FA, Barison A, Costa EV, Koolen HHF, de
Souza ADL and Pinheiro MLB: Integrative approach based on leaf
spray mass spectrometry, HPLC-DAD-MS/MS, and NMR for comprehensive
characterization of isoquinoline-derived alkaloids in leaves of
onychopetalum amazonicum. E. Fr. J Braz Chem Soc. 31:79–89.
2020.
|
|
7
|
Tungmunnithum D, Pinthong D and Hano C:
Flavonoids from nelumbo nucifera gaertn., a medicinal plant: Uses
in traditional medicine, phytochemistry and pharmacological
activities. Medicines (Basel). 5:1272018.PubMed/NCBI
|
|
8
|
Ren X, Chen H, Wang H, Wang Y, Huang C and
Pan H: Advances in the pharmacological effects and mechanisms of
Nelumbo nucifera gaertn. J Ethnopharmacol. 331:1182622024.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu Y, Zhao Q, Huang Q, Li Y, Yu J, Zhang
R, Liu J, Yan P, Xia J, Guo L, et al: Nuciferine regulates immune
function and gut microbiota in DSS-induced ulcerative colitis.
Front Vet Sci. 9:9393772022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu H, Yang Y, Guo S, Yang J, Jiang K, Zhao
G, Qiu C and Deng G: Nuciferine ameliorates inflammatory responses
by inhibiting the TLR4-Mediated pathway in
lipopolysaccharide-induced acute lung injury. Front Pharmacol.
8:9392017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen C, Duan F, Xie Y, Wan Q, Liu H, Gong
J, Huang L and Song Z: Nuciferine attenuates acute ischemic stroke
in a rat model: a metabolomic approach for the mechanistic study.
Mol Omics. 18:765–778. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo WH, Zhen GQ, Wu F, Lv YP, Yan JL, Zu
JN and Song CC: Nuciferine inhibits osteoclast formation through
suppressing glycolysis metabolic programming and ROS production.
Kaohsiung J Med Sci. 40:1057–1067. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xie W, Chen S, Wang W, Qin X, Kong C and
Wang D: Nuciferine reduces vascular leakage and improves cardiac
function in acute myocardial infarction by regulating the PI3K/AKT
pathway. Sci Rep. 14:70862024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wan Y, Xia J, Xu JF, Chen L, Yang Y, Wu
JJ, Tang F, Ao H and Peng C: Nuciferine, an active ingredient
derived from lotus leaf, lights up the way for the potential
treatment of obesity and obesity-related diseases. Pharmacol Res.
175:1060022022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu X, Si F, Hao R, Zheng J and Zhang C:
Nuciferine protects against obesity-induced nephrotoxicity through
its hypolipidemic, anti-inflammatory, and antioxidant effects. J
Agric Food Chem. 71:18769–18779. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu J, Ying A and Shi T: Nuciferine
inhibits skin cutaneous melanoma cell growth by suppressing
TLR4/NF-κB signaling. Anticancer Agents Med Chem. 20:2099–2105.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie JR, Chen XJ and Zhou G: Nuciferine
inhibits oral squamous cell carcinoma partially through suppressing
the STAT3 signaling pathway. Int J Mol Sci. 24:145322023.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu W, Yi DD, Guo JL, Xiang ZX, Deng LF
and He L: Nuciferine, extracted from Nelumbo nucifera Gaertn,
inhibits tumor-promoting effect of nicotine involving Wnt/β-catenin
signaling in non-small cell lung cancer. J Ethnopharmacol.
165:83–93. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou Y, Chen Z, Lin Q, Yang Y, Hang Y,
Zhou X, Wu C and Xie Z: Nuciferine reduced fat deposition by
controlling triglyceride and cholesterol concentration in broiler
chickens. Poult Sci. 99:7101–7108. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma C, Li G, He Y, Xu B, Mi X, Wang H and
Wang Z: Pronuciferine and nuciferine inhibit lipogenesis in 3T3-L1
adipocytes by activating the AMPK signaling pathway. Life Sci.
136:120–125. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu Y, Lu J, Sun L, Lyu X, Chang XY, Mi X,
Hu MG, Wu C and Chen X: Akkermansia muciniphila: A potential novel
mechanism of nuciferine to improve hyperlipidemia. Biomed
Pharmacother. 133:1110142021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Farrell MS, McCorvy JD, Huang XP, Urban
DJ, White KL, Giguere PM, Doak AK, Bernstein AI, Stout KA, Park SM,
et al: In vitro and in vivo characterization of the alkaloid
nuciferine. PLoS One. 11:e01506022016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ye LH, He XX, You C, Tao X, Wang LS, Zhang
MD, Zhou YF and Chang Q: Pharmacokinetics of nuciferine and
n-nornuciferine, two major alkaloids from nelumbo nucifera leaves,
in rat plasma and the brain. Front Pharmacol. 9:9022018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Wu X, Mi Y, Zhang B, Gu S, Liu G
and Li X: PLGA nanoparticles for the oral delivery of nuciferine:
preparation, physicochemical characterization and in vitro/in vivo
studies. Drug Deliv. 24:443–451. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bharathi R, Harini G, Sankaranarayanan A,
Shanmugavadivu A, Vairamani M and Selvamurugan N: Nuciferine-loaded
chitosan hydrogel-integrated 3D-printed polylactic acid scaffolds
for bone tissue engineering: A combinatorial approach. Int J Biol
Macromol. 253((Pt 7)): 1274922023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu S, Xu W, Liu J, Guan F, Xu A, Zhao J
and Ge J: Preparation of microgel co-loaded with nuciferine and
epigallocatechin-3-gallate for the regulation of lipid metabolism.
Front Nutr. 9:10697972022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ye LH, He XX, Kong LT, Liao YH, Pan RL,
Xiao BX, Liu XM and Chang Q: Identification and characterization of
potent CYP2D6 inhibitors in lotus leaves. J Ethnopharmacol.
153:190–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu L, Xu W, Zhang X, Su J, Liu X, Li H and
Zhang W: In-vitro and in-vivo evaluations of cytochrome P450 1A2
interactions with nuciferine. J Pharm Pharmacol. 62:658–662. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu XT, Liu TT, Xu HL, Chen QX and Wang Q:
Inhibitory kinetics and bioactivities of Nuciferine and Methyl
Ganoderate on Mucor miehei lipase and 3T3-L1 preadipocytes. Int J
Biol Macromol. 163:1719–1728. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li T, Chen H, Guo Y, Huang M, Liu P,
Aikemu A, Mohammadtursun N, Pan X and Yang X: Nuciferine restores
autophagy via the PI3K-AKT-mTOR pathway to alleviate renal fibrosis
in diabetic kidney disease. J Agric Food Chem. 73:5223–5235. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rapuru R, Begum RF, Singh SA, Vellapandian
C, Ali N, AlAsmari AF and Prajapati BG: Exploring the therapeutic
potential of leriodenine and nuciferine from Nelumbo nucifera for
renal fibrosis: An In-silico analysis. Z Naturforsch C J Biosci.
80:673–689. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiong X, Tang N, Lai X, Zhang J, Wen W, Li
X, Li A, Wu Y and Liu Z: Insights into amentoflavone: A natural
multifunctional biflavonoid. Front Pharmacol. 12:7687082021.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang MX, Zhao XJ, Chen TY, Liu YL, Jiao
RQ, Zhang JH, Ma CH, Liu JH, Pan Y and Kong LD: Nuciferine
alleviates renal injury by inhibiting inflammatory responses in
fructose-fed rats. J Agric Food Chem. 64:7899–7910. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li D, Liu B, Fan Y, Liu M, Han B, Meng Y,
Xu X, Song Z, Liu X, Hao Q, et al: Nuciferine protects against
folic acid-induced acute kidney injury by inhibiting ferroptosis.
Br J Pharmacol. 178:1182–1199. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen X, Zheng X, Zhang M, Yin H, Jiang K,
Wu H, Dai A and Yang S: Nuciferine alleviates LPS-induced mastitis
in mice via suppressing the TLR4-NF-kappaB signaling pathway.
Inflamm Res. 67:903–911. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kulhari U, Kundu S, Mugale MN and Sahu BD:
Nuciferine alleviates intestinal inflammation by inhibiting
MAPK/NF-ĸB and NLRP3/Caspase 1 pathways in vivo and in vitro. Int
Immunopharmacol. 115:1096132023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li J, Dong S, Quan S, Ding S, Zhou X, Yu
Y, Wu Y, Huang W, Shi Q and Li Q: Nuciferine reduces inflammation
induced by cerebral ischemia-reperfusion injury through the
PI3K/Akt/NF-kappaB pathway. Phytomedicine. 125:1553122024.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang L, Gao J, Tang P, Chong L, Liu Y,
Liu P, Zhang X, Chen L and Hou C: Nuciferine inhibits LPS-induced
inflammatory response in BV2 cells by activating PPAR-ү. Int
Immunopharmacol. 63:9–13. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim SM, Park EJ and Lee HJ: Nuciferine
attenuates lipopolysaccharide-stimulated inflammatory responses by
inhibiting p38 MAPK/ATF2 signaling pathways. Inflammopharmacology.
30:2373–2383. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kashiwada Y, Aoshima A, Ikeshiro Y, Chen
YP, Furukawa H, Itoigawa M, Fujioka T, Mihashi K, Cosentino LM,
Morris-Natschke SL and Lee KH: Anti-HIV benzylisoquinoline
alkaloids and flavonoids from the leaves of Nelumbo nucifera, and
structure-activity correlations with related alkaloids. Bioorg Med
Chem. 13:443–448. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang DD, Chutiwitoonchai N, Wang F, Tian
P, Sureram S, Lei X, Mahidol C, Ruchirawat S and Kittakoop P:
Effects of organic salts of virucidal and antiviral compounds from
Nelumbo nucifera and Kaempferia parviflora against SARS-CoV-2. Sci
Rep. 15:63802025. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sies H: Oxidative stress: A concept in
redox biology and medicine. Redox Biol. 4:180–183. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen X, Zhang A, Zhao K, Gao H, Shi P,
Chen Y, Cheng Z, Zhou W and Zhang Y: The role of oxidative stress
in intervertebral disc degeneration: Mechanisms and therapeutic
implications. Ageing Res Rev. 98:1023232024. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jelic MD, Mandic AD, Maricic SM and
Srdjenovic BU: Oxidative stress and its role in cancer. J Cancer
Res Ther. 17:22–28. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Harishkumar R, Manjari MS, Rose C and
Selvaraj CI: Protective effect of Nelumbo nucifera (Gaertn.)
against H(2)O(2)-induced oxidative stress on H9c2 cardiomyocytes.
Mol Biol Rep. 47:1117–1128. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Charoensin S and Weera W: Preventive
effect of nuciferine on H(2)O(2)-Induced fibroblast senescence and
pro-inflammatory cytokine gene expression. Molecules. 27:81482022.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xue K, Zhang G, Zhou Y, Wang K, Yao Z,
Chen J, Zhang Y, Li Z, Li Z, Zheng Z, et al: Nuciferine improves
random skin flap survival via TFEB-mediated activation of
autophagy-lysosomal pathway. Int Immunopharmacol. 119:1102042023.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Veerichetty V, Saravanabavan I, Pradeep A
and Abiraamasundari R: Development of gummy bear supplements and in
vitro exploration of antioxidant and antiproliferative potential of
Nuciferine. J Ayurveda Integr Med. 15:1008682024. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Qiu J, Le Y, Liu N, Chen L, Jiang Y, Wang
Y, Fan X, Rong X, Yu Z, Li S and Dou X: Nuciferine Alleviates
High-Fat Diet- and ApoE(−/-)-induced hepatic steatosis and
ferroptosis in NAFLD Mice via the PPARα signaling pathway. J Agric
Food Chem. 72:24417–24431. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Fang Z, Jiang X, Wang S, Tai W, Jiang Q,
Loor JJ, Yu H, Hao X, Chen M, Shao Q, et al: Nuciferine protects
bovine hepatocytes against free fatty acid-induced oxidative damage
by activating the transcription factor EB/peroxisome
proliferator-activated receptor gamma coactivator 1 alpha pathway.
J Dairy Sci. 107:625–640. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Nguyen KH, Ta TN, Pham TH, Nguyen QT, Pham
HD, Mishra S and Nyomba BL: Nuciferine stimulates insulin secretion
from beta cells-an in vitro comparison with glibenclamide. J
Ethnopharmacol. 142:488–495. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang MX, Liu YL, Yang Y, Zhang DM and Kong
LD: Nuciferine restores potassium oxonate-induced hyperuricemia and
kidney inflammation in mice. Eur J Pharmacol. 747:59–70. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ye LH, Xiao BX, Liao YH, Liu XM, Pan RL
and Chang Q: Metabolism profiles of nuciferine in rats using
ultrafast liquid chromatography with tandem mass spectrometry.
Biomed Chromatogr. 30:1216–1222. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wu XL, Wu MJ, Chen XZ, Ma HL, Ding LQ, Qiu
F, Pan Q and Zhang DQ: Metabolic profiling of nuciferine in rat
urine, plasma, bile and feces after oral administration using
ultra-high performance liquid chromatography-diode array
detection-quadrupole time-of-flight mass spectrometry. J Pharm
Biomed Anal. 140:71–80. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Gao H, Zhang L, Zhu A, Liu X, Wang T, Wan
M, Yang X and Zhang Y and Zhang Y: Metabolic profiling of
nuciferine in vivo and in vitro. J Agric Food Chem. Novemebr
18–2020.(Epub ahead of print). View Article : Google Scholar
|
|
56
|
Li L, Lei H, Wang W, Du W, Yuan J, Tu M,
Zhou H, Zeng S and Jiang H: Co-administration of nuciferine reduces
the concentration of metformin in liver via differential inhibition
of hepatic drug transporter OCT1 and MATE1. Biopharm Drug Dispos.
39:411–419. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang LM, Wang P, Teka T, Zhang YC, Yang
WZ, Zhang Y, Wang T, Liu LX, Han LF and Liu CX: 1H NMR
and UHPLC/Q-Orbitrap-MS-based metabolomics combined with 16S rRNA
gut microbiota analysis revealed the potential regulation mechanism
of nuciferine in hyperuricemia rats. J Agric Food Chem.
68:14059–14070. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Xu H, Lyu X, Guo X, Yang H, Duan L, Zhu H,
Pan H, Gong F and Wang L: Distinct AMPK-Mediated FAS/HSL pathway is
implicated in the alleviating effect of nuciferine on obesity and
hepatic steatosis in HFD-Fed mice. Nutrients. 14:18982022.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Tang Z, Luo T, Huang P, Luo M, Zhu J, Wang
X, Lin Q, He Z, Gao P and Liu S: Nuciferine administration in
C57BL/6J mice with gestational diabetes mellitus induced by a
high-fat diet: The improvement of glycolipid disorders and
intestinal dysbacteriosis. Food Funct. 12:11174–11189. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Du X, Di Malta C, Fang Z, Fang Z, Shen T,
Niu X, Chen M, Jin B, Yu H, Lei L, et al: Nuciferine protects
against high-fat diet-induced hepatic steatosis and insulin
resistance via activating TFEB-mediated autophagy-lysosomal
pathway. Acta Pharm Sin B. 12:2869–2886. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sun J, Fan J, Li T, Yan X and Jiang Y:
Nuciferine protects against high-fat diet-induced hepatic steatosis
via modulation of gut microbiota and bile acid metabolism in rats.
J Agric Food Chem. 70:12014–12028. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Li J, Zhao C, Liu M, Chen L, Zhu Y, Gao W,
Du X, Song Y, Li X, Liu G, et al: Nuciferine ameliorates
nonesterified fatty acid-induced bovine mammary epithelial cell
lipid accumulation, apoptosis, and impaired migration via
activating LKB1/AMPK signaling pathway. J Agric Food Chem.
71:443–456. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Li F, Zhao X, Xie F, Wang Z, Ding H, Wang
W, Jiao R, Pan Y and Kong L: Nuciferine blocks MIB2-mediated CARD6
polyubiquitination and degradation in the amelioration of high
fructose-induced liver lipid accumulation. Food Funct.
14:4706–4721. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yan C, Zhan Y, Yuan S, Cao Y, Chen Y, Dong
M, Zhang H, Chen L, Jiang R, Liu W, et al: Nuciferine prevents
obesity by activating brown adipose tissue. Food Funct. 15:967–976.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Guo F, Yang X, Li X, Feng R, Guan C, Wang
Y, Li Y and Sun C: Nuciferine prevents hepatic steatosis and injury
induced by a high-fat diet in hamsters. PLoS One. 8:e637702013.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Yin J, Luo Y, Deng H, Qin S, Tang W, Zeng
L and Zhou B: Hugan Qingzhi medication ameliorates hepatic
steatosis by activating AMPK and PPARalpha pathways in L02 cells
and HepG2 cells. J Ethnopharmacol. 154:229–239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhang DD, Zhang JG, Wu X, Liu Y, Gu SY,
Zhu GH, Wang YZ, Liu GL and Li XY: Nuciferine downregulates
Per-Arnt-Sim kinase expression during its alleviation of
lipogenesis and inflammation on oleic acid-induced hepatic
steatosis in HepG2 cells. Front Pharmacol. 6:2382015. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhang C, Deng J, Liu D, Tuo X, Xiao L, Lai
B, Yao Q, Liu J, Yang H and Wang N: Nuciferine ameliorates hepatic
steatosis in high-fat diet/streptozocin-induced diabetic mice
through a PPARα/PPARү coactivator-1α pathway. Br J Pharmacol.
175:4218–4228. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ning Q, Wang Y, Zhang Y, Shen G, Xie Z and
Pang J: Nuciferine prevents hepatic steatosis by regulating lipid
metabolismin diabetic rat model. Open Life Sci. 14:699–706. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Xu H, Wang L, Yan K, Zhu H, Pan H, Yang H,
Liu M and Gong F: Nuciferine inhibited the differentiation and
lipid accumulation of 3T3-L1 preadipocytes by regulating the
expression of lipogenic genes and adipokines. Front Pharmacol.
12:6322362021. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Li J, Liu M, Fan M, Tian Q, Wang J, Du Y,
Yu J, Li X, Yang L, Zhao M, et al: Nuciferine ameliorates
blood-brain barrier disruption post-ischemic stroke via inhibiting
the JAK2/STAT3 pathway. Phytomedicine. 143:1568292025. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Wu L, Chen C, Li Y, Guo C, Fan Y, Yu D,
Zhang T, Wen B, Yan Z and Liu A: UPLC-Q-TOF/MS-based serum
metabolomics reveals the anti-ischemic stroke mechanism of
nuciferine in MCAO rats. ACS Omega. 5:33433–33444. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Khan S, Khan HU, Khan FA, Shah A, Wadood
A, Ahmad S, Almehmadi M, Alsaiari AA, Shah FU and Kamran N:
Anti-Alzheimer and antioxidant effects of nelumbo nucifera L.
Alkaloids, nuciferine and norcoclaurine in alloxan-induced diabetic
albino rats. Pharmaceuticals (Basel). 15:12052022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Chen C, Ma Q, Jiang J, Wang T, Qiu L and
Liu A: Protective effects of nuciferine in middle cerebral artery
occlusion rats based on transcriptomics. Brain Sci. 12:5722022.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Nguyen A, Lee P, Rodriguez EK, Chahal K,
Freedman BR and Nazarian A: Addressing the growing burden of
musculoskeletal diseases in the ageing US population: Challenges
and innovations. Lancet Healthy Longev. 6:1007072025. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Song C, Cao J, Lei Y, Chi H, Kong P, Chen
G, Yu T, Li J, Kumar Prajapati R, Xia J and Yan J: Nuciferine
prevents bone loss by disrupting multinucleated osteoclast
formation and promoting type H vessel formation. FASEB J.
34:4798–4811. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wen H, Zhou S, Li J, Peng F, Han X and Li
H: Nuciferine attenuates the progression of osteoarthritis by
targeting PI3K/Akt/NF-κB signaling pathway. J Funct Food.
86:1046822021. View Article : Google Scholar
|
|
78
|
Peng M, Shen G, Tu Q, Zhang W and Wang J:
Nuciferine ameliorates osteoarthritis: An in vitro and in vivo
study. Int Immunopharmacol. 142((Pt B)): 1130982024. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Wang H, Geng X, Ai F, Yu Z, Zhang Y, Zhang
B, Lv C, Gao R, Yue B and Dou W: Nuciferine alleviates
collagen-induced arthritic in rats by inhibiting the proliferation
and invasion of human arthritis-derived fibroblast-like
synoviocytes and rectifying Th17/Treg imbalance. Chin J Nat Med.
22:341–355. 2024.PubMed/NCBI
|
|
80
|
Kulhari U, Ambujakshan A, Ahmed M,
Washimkar K, Kachari J, Mugale MN and Sahu BD: Nuciferine inhibits
TLR4/NF-ĸB/MAPK signaling axis and alleviates adjuvant-induced
arthritis in rats. Eur J Pharmacol. 982:1769402024. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wang X, Cheang WS, Yang H, Xiao L, Lai B,
Zhang M, Ni J, Luo Z, Zhang Z, Huang Y and Wang N: Nuciferine
relaxes rat mesenteric arteries through endothelium-dependent and
-independent mechanisms. Br J Pharmacol. 172:5609–5618. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Deng H, Xu Q, Sang XT, Huang X, Jin LL,
Chen FE, Shen QK, Quan ZS and Cao LH: Study on the vasodilatory
activity of lotus leaf extract and its representative substance
nuciferine on thoracic aorta in rats. Front Pharmacol.
13:9464452022. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Cho S, Cho HW, Woo KW, Jeong J, Lim J,
Park S, Seo M and Lim S: Nelumbo nucifera Receptaculum extract
suppresses angiotensin II-induced cardiomyocyte hypertrophy.
Molecules. 24:16472019. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Harishkumar R, Christopher JG, Ravindran R
and Selvaraj CI: Nuciferine attenuates doxorubicin-induced
cardiotoxicity: An in vitro and in vivo study. Cardiovasc Toxicol.
21:947–963. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Harishkumar R and Selvaraj CI: Nuciferine
from Nelumbo nucifera Gaertn. attenuates isoproterenol-induced
myocardial infarction in Wistar rats. Biotechnol Appl Biochem.
69:1176–1189. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Li R, Qin X, Yue L, Liu W, Gao Y, Zhu F,
Wang D and Zhou Q: Nuciferine improves cardiac function in mice
subjected to myocardial ischemia/reperfusion injury by upregulating
PPAR-ү. Heliyon. 9:e136302023. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Xiao M, Xian C, Wang Y, Qi X, Zhang R, Liu
Z and Cheng Y: Nuciferine attenuates atherosclerosis by regulating
the proliferation and migration of VSMCs through the
Calm4/MMP12/AKT pathway in ApoE((−/-)) mice fed with High-Fat-Diet.
Phytomedicine. 108:1545362023. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wei H, Yin Y, Yang W, Zhu J, Chen L, Guo
R, Yang Z and Li S: Nuciferine induces autophagy to relieve
vascular cell adhesion molecule 1 activation via repressing the
Akt/mTOR/AP1 signal pathway in the vascular endothelium. Front
Pharmacol. 14:12643242023. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Zhou YX, Wang WP, Ke J, Ou HP, Chen LY,
Hou AG, Li P, Ma YS and Bin Jin W: Nuciferine analogs block
voltage-gated sodium, calcium and potassium channels to regulate
the action potential and treat arrhythmia. Biomed Pharmacother.
179:1174222024. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Mukherjee PK, Mukherjee D, Maji AK, Rai S
and Heinrich M: The sacred lotus (Nelumbo nucifera) - phytochemical
and therapeutic profile. J Pharm Pharmacol. 61:407–422. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Nakamura S, Nakashima S, Tanabe G, Oda Y,
Yokota N, Fujimoto K, Matsumoto T, Sakuma R, Ohta T, Ogawa K, et
al: Alkaloid constituents from flower buds and leaves of sacred
lotus (Nelumbo nucifera, Nymphaeaceae) with melanogenesis
inhibitory activity in B16 melanoma cells. Bioorg Med Chem.
21:779–787. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Wu PF, Chiu CC, Chen CY and Wang HM:
7-Hydroxydehydronuciferine induces human melanoma death via
triggering autophagy and apoptosis. Exp Dermatol. 24:930–935. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Bai X, Liu X, Li S, An H, Kang X and Guo
S: Nuciferine inhibits TMEM16A in dietary adjuvant therapy for lung
cancer. J Agric Food Chem. 70:3687–3696. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Gautam RK, Bhardwaj S and Kushwaha S:
Nuciferine inhibits epithelial-mesenchymal transition (EMT) in A549
cells and ameliorates bleomycin-induced pulmonary fibrosis in mice
via the TGF-β1/Smad2/3 signaling pathway. Mol Nutr Food Res.
69:e701312025. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Qi Q, Li R, Li HY, Cao YB, Bai M, Fan XJ,
Wang SY, Zhang B and Li S: Identification of the anti-tumor
activity and mechanisms of nuciferine through a network
pharmacology approach. Acta Pharmacol Sin. 37:963–972. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Okayama M, Matsumoto T, Kitagawa T,
Nakamura S, Ohta T, Yoshida T and Watanabe T: Cytotoxic activities
of alkaloid constituents from the climbing stems and rhizomes of
Sinomenium acutum against cancer stem cells. J Nat Med. 78:226–235.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Liu RM, Xu P, Chen Q, Feng SL and Xie Y: A
multiple-targets alkaloid nuciferine overcomes paclitaxel-induced
drug resistance in vitro and in vivo. Phytomedicine. 79:1533422020.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Kang EJ, Lee SK, Park KK, Son SH, Kim KR
and Chung WY: Liensinine and nuciferine, bioactive components of
nelumbo nucifera, inhibit the growth of breast cancer cells and
breast cancer-associated bone loss. Evid Based Complement Alternat
Med. 2017:15831852017. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Tong Y, Li Z, Wu Y, Zhu S, Lu K and He Z:
Lotus leaf extract inhibits ER(−) breast cancer cell migration and
metastasis. Nutr Metab (Lond). 18:202021. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Zheng L, Jiang H, Li R, Song L, Chen R and
Dong H: The pharmacological mechanisms of xiaochaihutang in
treating breast cancer based on network pharmacology. Contrast
Media Mol Imaging. 2022:39006362022. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Zhou L, Wang Q, Zhang H, Li Y, Xie S and
Xu M: YAP inhibition by nuciferine via AMPK-Mediated Downregulation
of HMGCR sensitizes pancreatic cancer cells to gemcitabine.
Biomolecules. 9:6202019. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Li QH, Sui LP, Zhao YH, Chen BG, Li J, Ma
ZH, Hu ZH, Tang YL and Guo YX: Tripartite motif-containing 44 is
involved in the tumorigenesis of laryngeal squamous cell carcinoma,
and its expression is downregulated by nuciferine. Tohoku J Exp
Med. 254:17–23. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Li T, Wang W, Zhu M, Dong T, Jiang J, Li
Z, An T, Chen X, Mao Y, Chen Y and Yang X: The antineoplastic
effects of nuciferine on hepatocellular carcinoma are associated
with suppression of the HER2-AKT/ERK1/2 signaling pathway. Discov
Oncol. 16:8222025. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Glaviano A, Foo ASC, Lam HY, Yap KCH,
Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, et al:
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies
in cancer. Mol Cancer. 22:1382023. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
An X, Ma L, Bai Y, Chen C, Liu J, Dawuti
A, Zeng K, Yang B, Han B and Abulizi A: Nuciferine attenuates
cancer cachexia-induced muscle wasting in mice via HSP90AA1. J
Cachexia Sarcopenia Muscle. 16:e137772025. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Oeckinghaus A and Ghosh S: The NF-kappaB
family of transcription factors and its regulation. Cold Spring
Harb Perspect Biol. 1:a0000342009. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Mao H, Zhao X and Sun SC: NF-ĸB in
inflammation and cancer. Cell Mol Immunol. 22:811–839. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Yu H, Lin L, Zhang Z, Zhang H and Hu H:
Targeting NF-ĸB pathway for the therapy of diseases: Mechanism and
clinical study. Signal Transduct Target Ther. 5:2092020. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Rawla P, Sunkara T and Gaduputi V:
Epidemiology of pancreatic cancer: Global trends, etiology and risk
factors. World J Oncol. 10:10–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Wang J, Xiang H, Lu Y and Wu T: Role and
clinical significance of TGF-β1 and TGF-βR1 in malignant tumors
(Review). Int J Mol Med. 47:552021. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Su E, Han X and Jiang G: The transforming
growth factor beta 1/SMAD signaling pathway involved in human
chronic myeloid leukemia. Tumori. 96:659–666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu
Y, Dong Q and Wei X: Wnt/β-catenin signaling pathway in
carcinogenesis and cancer therapy. J Hematol Oncol. 17:462024.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Zou S, Tong Q, Liu B, Huang W, Tian Y and
Fu X: Targeting STAT3 in cancer immunotherapy. Mol Cancer.
19:1452020. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Zhang P, Wang J, Zhao Y, Zhang X, Qu L,
Wang C, Feng J, Wang A, Zhou W, Liu Y, et al: Discovery of novel
antagonists on β(2)-adrenoceptor from natural products using a
label-free cell phenotypic assay. Naunyn Schmiedebergs Arch
Pharmacol. 391:1411–1420. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Heng HL, Chee CF, Chin SP, Ouyang Y, Wang
H, Buckle MJC, Herr DR, Paterson IC, Doughty SW, Abd Rahman N and
Chung LY: Synthesis and evaluation of nuciferine and roemerine
enantiomers as 5-HT(2) and alpha(1) receptor antagonists.
Medchemcomm. 9:576–582. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Guan JW, Xu Y, Yu W, Wei LH, Xue R, Yu H,
Fan JM, Wang HZ, Abulizi A, Chen W and Han B: Biosensor-based
active ingredient recognition system for screening TNF-α inhibitors
from lotus leaves. Anal Bioanal Chem. 415:1641–1655. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Ding C, Ruan J, Huang J, Liu L, Li Y, Du Y
and Zhao Y: Nuciferine activates intestinal TAS2R46 to attenuate
metabolic disorders and hyperlipidemia via hepatic VLDL regulation.
Phytomedicine. 142:1568002025. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Zhang H, Chen G, Zhang Y, Yang M, Chen J
and Guo M: Potential hypoglycemic, hypolipidemic, and
anti-inflammatory bioactive components in Nelumbo nucifera leaves
explored by bioaffinity ultrafiltration with multiple targets. Food
Chem. 375:1318562022. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Zhang YK, Chen JS, Wang MM, Wang CZ, Wang
MX, Wang Z, Yang QL, Sun B, Sun JY, Liu YF and Liu C: Synthesis and
bioactivity evaluation of novel nuciferine derivatives with
antihyperuricemia and nephroprotective effects. Bioorg Chem.
126:1059162022. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Ishrat N, Gupta A, Khan MF, Shahab U, Khan
MS, Ahmad N, Kaur K, Ahmad S and Mahdi AA: Phytoconstituents of
Nymphaea rubra flowers and their anti-diabetic metabolic targets.
Fitoterapia. 176:1060142024. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Veerichetty V and Saravanabavan I:
Molecular docking study of nuciferine as a tyrosinase inhibitor and
its therapeutic potential for hyperpigmentation. Genomics Inform.
21:e432023. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Zhao X, Hou T, Zhou H, Liu Z, Liu Y, Wang
C, Guo Z, Yu D, Xu Q, Wang J and Liang X: Multi-effective
components and their target mechanism of Ziziphi Spinosae Semen in
the treatment of insomnia. Fitoterapia. 171:1057122023. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Zhou Z, Qi J, Wu Y, Li C, Bao W, Lin X and
Zhu A: Nuciferine effectively protects mice against
acetaminophen-induced liver injury. Antioxidants. 12:9492023.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Li H, Li W, Wu Y, Wu H and Cai X:
Integrating network pharmacology and animal experimental validation
to investigate the mechanism of lotus leaf in obesity. Int
Immunopharmacol. 145:1137192025. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Lu J, Xu YT, Qian XL, Zhu DX, Lu JY, Ma H
and Liu J: Preparation, pharmacokinetics and anti-obesity effects
on dogs of nuciferine liposomes. Vet Med Sci. 10:e700172024.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Huang X, Hao N, Chen G, Liu S and Che Z:
Chemistry and biology of nuciferine. Industrial Crops and Products.
179:1146942022. View Article : Google Scholar
|
|
127
|
Zhao D, Ma L, Brownlie J, Tonissen K, Pan
Y and Feng Y: Neuroprotective potential of major alkaloids from
nelumbo nucifera (Lotus): Mechanisms and therapeutic implications.
Int J Mol Sci. 26:82802025. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Yang X, Yu MF, Lei J, Peng YB, Zhao P, Xue
L, Chen W, Ma LQ, Liu QH and Shen J: Nuciferine relaxes tracheal
rings via the blockade of VDLCC and NSCC channels. Planta Med.
84:83–90. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Xiong WT, Liao JB, Yang ZX, Cui HT, Zhang
ZY, Wen WB and Wang HW: Effect of nuciferine on gut microbiota and
inflammatory response in obese model mice. Zhongguo Zhong Yao Za
Zhi. 46:2104–2111. 2021.(In Chinese). PubMed/NCBI
|
|
130
|
Cui H, Li Y, Cao M, Liao J, Liu X, Miao J,
Fu H, Song R, Wen W, Zhang Z and Wang H: Untargeted metabolomic
analysis of the effects and mechanism of nuciferine treatment on
rats with nonalcoholic fatty liver disease. Front Pharmacol.
11:8582020. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Liu CM, Kao CL, Wu HM, Li WJ, Huang CT, Li
HT and Chen CY: Antioxidant and anticancer aporphine alkaloids from
the leaves of Nelumbo nucifera Gaertn. cv. Rosa-plena. Molecules.
19:17829–17838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Liu W, Chen X, Ge Y, Wang H, Phosat C, Li
J, Mao HP, Gao XM and Chang YX: Network pharmacology strategy for
revealing the pharmacological mechanism of pharmacokinetic target
components of San-Ye-Tang-Zhi-Qing formula for the treatment of
type 2 diabetes mellitus. J Ethnopharmacol. 260:1130442020.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Wang Y, Yao W, Li B, Qian S, Wei B, Gong
S, Wang J, Liu M and Wei M: Nuciferine modulates the gut microbiota
and prevents obesity in high-fat diet-fed rats. Exp Mol Med.
52:1959–1975. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Shi Z, Fang ZY, Gao XX, Yu H, Zhu YW,
Ouyang HL, Song YX, Du XL, Wang Z, Li XW and Liu GW: Nuciferine
improves high-fat diet-induced obesity via reducing intestinal
permeability by increasing autophagy and remodeling the gut
microbiota. Food Funct. 12:5850–5861. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Chan JD, Acharya S, Day TA and Marchant
JS: Pharmacological profiling an abundantly expressed schistosome
serotonergic GPCR identifies nuciferine as a potent antagonist. Int
J Parasitol Drugs Drug Resist. 6:364–370. 2016. View Article : Google Scholar : PubMed/NCBI
|
